Location not specified
Reported 6 hours ago(Mar 9, 2026, 2:01 PM)
A plaintiff achieved partial success against AstraZeneca at the German Federal Court of Justice regarding hearing loss following COVID-19 vaccination.
COVID-19 vaccine concerns escalate with hearing loss cases emerging and assessment costs spiraling to £48m. The replacement of the assessment firm after costs ballooned eightfold highlights growing scrutiny of vaccine-related health impacts.
Updates are ordered chronologically. Entries marked below correspond to the view that led you here.
A plaintiff achieved partial success against AstraZeneca at the German Federal Court of Justice regarding hearing loss following COVID-19 vaccination.
Primary reportFirm assessing Covid vaccine harm replaced after costs spiral to £48m. The figure is eight times the amount originally estimated for the assessment work carried out by Crawford & Company Adjusters.